Urgessa, Fekadu
Jenkins, Isaac
Tsegaye, Aster
Nigussie, Helen
Kuru, Teklu
Gebremedhin, Amha
Abdela, Fozia
Tadesse, Fisihatsion
Radich, Jerald
Article History
Received: 14 July 2025
Accepted: 22 August 2025
First Online: 29 August 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the College Institutional Review Board (IRB), College of Health Science, Addis Ababa University (protocol number 026/21/lab) before starting the study. In addition, the study was reviewed by the hematology unit, and internal medicine departmental ethical committee before starting the data collection. Further, before sending the sample to the collaborator Institute, Fred Hutchinson Cancer Research Center, we have granted national ethical clearance from the National Research Ethics Review Committee (NRERC) (Ref no 03/246/951/22). All the procedures have been conducted according to the Declaration of Helsinki. Informed consent was taken from all the leukemic patients before starting blood sample collection. For those who cannot read and write cases, we tried to make everything clear to them by reading the information sheet and consent form to understand the aim of the study and to participate voluntarily. Finally, all privacy of the study population is kept secret.